Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies-Reference-Cited by-同舟云学术

Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies

Published:2018-03 Issue:10123 Volume:391 Page:839-849
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Llibre Josep M,Hung Chien-Ching,Brinson Cynthia,Castelli Francesco,Girard Pierre-Marie,Kahl Lesley P,Blair Elizabeth A,Angelis Kostas,Wynne Brian,Vandermeulen Kati,Underwood Mark,Smith Kim,Gartland Martin,Aboud Michael

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Efficacy and safety of contemporary dual-drug antiretroviral regimens as first-line treatment or as a simplification strategy: a systematic review and meta-analysis;Achhra;Lancet HIV,2016

2. Dual therapy treatment strategies for the management of patients infected with HIV: a systematic review of current evidence in ARV-naive or ARV-experienced, virologically suppressed patients;Baril;PLoS One,2016

3. Two-drug treatment approaches in HIV: finally getting somewhere?;Kelly;Drugs,2016

4. Risk of HIV escape using sub-optimal antiretroviral dual or monotherapy;de Mendoza;AIDS Rev,2016

5. Pharmacokinetics and safety of S/GSK1349572, a next-generation HIV integrase inhibitor, in healthy volunteers;Min;Antimicrob Agents Chemother,2010

Cited by 299 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA);The Journal of Infectious Diseases;2024-09-03

2. Identification and simultaneous quantification of potential genotoxic impurities in first-line HIV drug dolutegravir sodium using fast ultrasonication-assisted extraction method coupled with GC–MS and in-silico toxicity assessment;Journal of Chromatography B;2024-09

3. Current status of the small molecule anti-HIV drugs in the pipeline or recently approved;Bioorganic & Medicinal Chemistry;2024-09

4. Cytokines assets in PLWH in two-drug dolutergravir based or three-drug antiretroviral regimen;BMC Infectious Diseases;2024-07-03

5. Effectiveness of dolutegravir in moderate severity COVID-19 patients: A single-center, randomized, double-blind, placebo-controlled trial;BioImpacts;2024-06-26